ProfileGDS5822 / ILMN_2890284
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 80% 81% 80% 82% 83% 79% 83% 80% 80% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1143.580
GSM1276600PDAC Late Ablation Control 2160.381
GSM1276601PDAC Late Ablation Control 3197.180
GSM1276602PDAC Late Ablation 1173.382
GSM1276603PDAC Late Ablation 2202.483
GSM1276604PDAC Late Ablation 3143.679
GSM1303940PDAC Late Ablation_anti-CTLA4 1193.683
GSM1303941PDAC Late Ablation_anti-CTLA4 2177.180
GSM1303942PDAC Late Ablation_anti-CTLA4 3184.580